Asia-Pacific Journal of Clinical OncologyVolume 17, Issue S7 p. 12-12 ANZUP MDT MASTERCLASS CONVENOR WELCOMEFree Access Masterclass Convenor Welcome First published: 10 October 2021 https://doi.org/10.1111/ajco.13691AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text full-text accessPlease review our Terms and Conditions Use check ...

OBJECTIVE This study aimed to systematically evaluate maggot debridement therapy (MDT) in the treatment of chronically infected wounds and ulcers. METHODS We performed a meta-analysis referring to the PRISMA statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). We searched for published articles in the following databases: PubMed, Web of Science, Embase, Wanfang (Chi...

PURPOSE To explore the summation properties of a motion-displacement hyperacuity stimulus with respect to stimulus area and luminance, with the goal of applying the results to the development of a motion-displacement test (MDT) for the detection of early glaucoma. METHODS A computer-generated line stimulus was presented with displacements randomized between 0 and 40 minutes of arc (min arc). ...

New mythicomyiids from Baltic and Rovno amber are described and illustrated herein including one new genus: Riga, n. gen.; and five new species: Glabellula aggregata Evenhuis, n. sp., Glabellula perkovskyi Evenhuis, n. sp., Riga toni Evenhuis, n. sp., Carmenelectra shehuggme Evenhuis, n. sp. and Carmenelectra pernigra Evenhuis, n. sp. The genus Riga is very closely related to the extant genus R...

BACKGROUND The predictive value of the serology to detection of IgM against the Mycobacterium leprae-derived phenolic glycolipid-I/PGL-I to identify leprosy patients who are at higher risk of developing reactions remains controversial. Whether baseline results of the ML Flow test can predict leprosy reactions was investigated among a cohort of patients enrolled in The Clinical Trial for Uniform...

A lepromatous patient treated with dapsone in the pre-MDT era to the point of smear negativity (> 6 years), relapsed 5 years after stopping treatment. He was then put on WHO-MDT for multibacillary (MB) leprosy, and was treated again; he had negative slit skin smears (3 years). He again presented with a relapse of leprosy 17 years after stopping treatment, and this time he presented with borderl...